Analyst Recommendations

Piper Sandler analyst issues NEUTRAL recommendation for EWCZ on July 11, 2024 06:41AM ET. The previous analyst recommendation was Neutral.EWCZ was trading at $9.37 at issue of the...

July 11, 2024   EWCZ -1.56%

Guggenheim analyst issues BUY recommendation for ARRY on July 11, 2024 06:38AM ET. The previous analyst recommendation was Buy.ARRY was trading at $9.9 at issue of the analyst...

July 11, 2024   ARRY 1.62%

Piper Sandler analyst issues OVERWEIGHT recommendation for SBH on July 11, 2024 06:43AM ET. The previous analyst recommendation was Overweight.SBH was trading at $9.94 at issue of the...

July 11, 2024   SBH 1.22%

Piper Sandler analyst issues NEUTRAL recommendation for HIMS on July 11, 2024 06:41AM ET. The previous analyst recommendation was Neutral.HIMS was trading at $20.21 at issue of the...

July 11, 2024   HIMS 0.64%

Guggenheim analyst issues BUY recommendation for GSK on July 11, 2024 06:43AM ET. The previous analyst recommendation was Buy.GSK was trading at $38.56 at issue of the analyst...

July 11, 2024   GSK 1.24%

Piper Sandler analyst issues OVERWEIGHT recommendation for PLNT on July 11, 2024 06:42AM ET. The previous analyst recommendation was Overweight.PLNT was trading at $72.26 at issue of the...

July 11, 2024   PLNT -1.09%

Piper Sandler analyst issues OVERWEIGHT recommendation for KMB on July 11, 2024 06:42AM ET. The previous analyst recommendation was Overweight.KMB was trading at $140.79 at issue of the...

July 11, 2024   KMB 1.27%

OTR Global analyst issues NEGATIVE recommendation for SBUX on July 11, 2024 06:44AM ET. The previous analyst recommendation was Positive.SBUX was trading at $72.51 at issue of the...

July 11, 2024   SBUX 1.17%

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for SCHW on July 11, 2024 07:05AM ET. The previous analyst recommendation was Equal-Weight.SCHW was trading at $74.63 at issue of the...

July 11, 2024   SCHW 0.21%

Wedbush analyst issues OUTPERFORM recommendation for CAVA on July 11, 2024 06:46AM ET. The previous analyst recommendation was Outperform.CAVA was trading at $85.3 at issue of the analyst...

July 11, 2024   CAVA -1.26%